Journal article
Reduction in radiation dose for atrial fibrillation ablation over time: A 12-year single-center experience of 2344 patients
A Voskoboinik, ES Kalman, Y Savicky, PB Sparks, JB Morton, G Lee, PM Kistler, JM Kalman
Heart Rhythm | ELSEVIER SCIENCE INC | Published : 2017
Abstract
Background Pulmonary vein isolation (PVI) is a well-established treatment of atrial fibrillation (AF), with contact force (CF)–sensing catheters joining 3-dimensional mapping systems and image integration as technological advancements over the last decade. Objective The purpose of this study was to analyze trends in radiation exposure for AF ablation over the last 12 years at our center. Methods We reviewed prospectively collected data of 2344 consecutive PVI procedures for either paroxysmal or persistent AF between January 2004 and December 2015. During this period, all cases used 3-dimensional mapping systems, with 8 software and 2 hardware upgrades. Primary endpoints were fluoroscopy time..
View full abstractGrants
Funding Acknowledgements
Dr. Voskoboinik is supported by a co-funded National Health and Medical Research Council of Australia (NHMRC)/National Heart Foundation of Australia (NHF) post-graduate scholarship and Baker IDI Bright Sparks scholarship. Drs. Kistler and Kalman are supported by practitioner fellowships from the NHMRC. This research is supported in part by the Victorian Government's Operational Infrastructure Funding. Dr. Kalman sits on the advisory board of Biosense Webster and Boston Scientific; and receives research and fellowship support from Biosense Webster, Boston Scientific, St. Jude Medical, and Medtronic.